Results 121 to 130 of about 21,820 (216)

Ceftazidime-Avibactam Combination Therapy versus Monotherapy for the Treatment Carbapenem-Resistant Gram-Negative Bacterial Infections: A Retrospective Observational Study [PDF]

Keyang Li,1,* Debao Li,2,* Hongliang Dong,1 Dongmei Ren,2 Dandan Gong,1 Shubo Wang,1 Yang Li,1 Yuanyuan Wu,1 Jikang Yang,3 Wenjuan Yan,4 Yi Li4 1Department of Clinical Pharmacy, Jiaozuo People’s Hospital, Jiaozuo, Henan, People’s Republic of ...
Gong D, Li Y, Yang J, Li D, Dong H, Wang S, Li K, Ren D, Wu Y, Yan W   +9 more
core  

Ceftazidime–Avibactam Pharmacokinetic Comparative In Vivo/In Vitro Study in a Critically Ill Children Under High‐Volume Continuous Venovenous Hemodiafiltration

Pharmacology Research & Perspectives
Ceftazidime–avibactam is a novel cephalosporin/beta‐lactamase inhibitor combination developed to address increasing antimicrobial resistance. This report presents a comparative study of the pharmacokinetics of ceftazidime and avibactam, utilizing in ...
Michael Thy, Alexandre Debs, Gabrielle Lui, Leo Froelicher‐Bournaud, Jean‐Marc Tréluyer, Mehdi Oualha   +5 more
doaj   +1 more source

Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study [PDF]

Chen-Huan Yu,1 Mao-Song Tsai,2 Chun-Hsing Liao,2 Chia-Jui Yang2 1Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; 2Division of Infectious Disease, Department of Internal Medicine, Far Eastern Memorial Hospital, New
Tsai MS, Yu CH, Yang CJ, Liao CH
core  

Allergy to ceftazidime/avibactam: diagnosis and desensitization

Advances in Dermatology and Allergology
Cristallo, Mattia, Chaoul, Nada, Albanesi, Marcello, Nettis, Eustachio, Di Girolamo, Attilio   +4 more
openaire   +2 more sources

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam

, 2019
Objectives: We characterized the first ceftazidime-avibactam-resistant KPC-producing-Klebsiella pneumoniae clinical isolate detected in Greece, before the introduction of ceftazidime-avibactam in clinical practice. Methods: K.
Giamarellou, H., Kontopoulou, K., Antoniadou, A., Souli, M., Galani, I., Karaiskos, I.   +5 more
core   +1 more source

Severe hypokalemia induced by ceftazidime-avibactam: Case report. [PDF]

Medicine (Baltimore)
Yuan Y, Gu Y, Bai W, Liu W, Li W, Yin Y.
europepmc   +1 more source

Repeated insertions at positions 261-280 in KPC-2 highlight a ceftazidime-avibactam resistance hotspot. [PDF]

iScience
Li Y, Salman S, Liu R, Wang K, Gong L, Sun T, Xu H.   +6 more
europepmc   +1 more source

Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant <i>Escherichia coli</i>. [PDF]

Antimicrob Agents Chemother
Shropshire WC, Borjan J, Fonseca IY, Pham K, Guerrero M, Liboro K, Young A, Chung JK, Wu C-T, Manzanares A, Bhatti MM, Vuong NN, Handley G, Spallone A, Chemaly RF, Khan A, Shelburne S.   +16 more
europepmc   +1 more source

Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Organisms: A Prospective, Observational, Single-Center Study

Introduction: The World Health Organization has declared carbapenem-resistant organisms a research and development priority. Although ceftazidime–avibactam was approved around a decade ago, there is still a lack of prospective data on the treatment of ...
Frieder Pfäfflin, Anja Theloe, Leif Erik Sander, Stephan Achterberg, Rasmus Leistner, Miriam Songa Stegemann, Florian Kurth   +6 more
core   +1 more source

Ceftazidime-Avibactam Effectiveness in Carbapenem-Resistant Enterobacterales Bacteremia: A Retrospective Cohort Study in Korea. [PDF]

J Korean Med Sci
Lee Y, Seong JE, Lee JA, Kim JH, Ahn JY, Jeong SJ, Choi JY, Yeom JS, Ku NS.   +8 more
europepmc   +1 more source